Agilent to raise up to $1.4 billion from IPO (initial public offering)
This article was originally published in Clinica
Agilent Technologies, the testing and measurement business being spun off from Hewlett-Packard (H-P), expects to raise as much as $1.4 billion from an initial public offering of up to 65.5 million shares. The shares will be listed on the New York Stock Exchange under the stock symbol A.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.